Liminal BioSciences comments on Coronavirus (Covid-19)
LMNL commented today on the impact of the current COVID-19 pandemic on its operations
Liminal BioSciences reports fourth quarter and 2019 year end results
LMNL today reported its financial results for the fourth quarter and year-ended December 31, 2019.
Liminal BioSciences to report its fourth quarter and year-end 2019 financial results and hold conference call/webcast
LMNL announced today it will report its financial results for the fourth quarter and financial year ended December 31, 2019 on Friday March 20, 2020 after market close.
Liminal BioSciences announces scientific presentations at upcoming Keystone Symposia
LMNL announced the Company and its collaborators will present scientific findings at two upcoming Keystone Symposia
Liminal BioSciences announces upcoming investor presentation at BIO CEO & investor conference
Members of the management team will provide a business overview and update at the BIO CEO & Investor Conference taking place February 10-11, 2020 in New York, USA.
Liminal BioSciences outlines corporate priorities for 2020